Skip to content

    SMLT

    SMLT
    Capital Goods·13 Nov 2025
    Management Summary

    Sarthak Metals Limited reported a challenging Q2 FY26 for its core cored wire business, with volumes declining 14% YoY due to low steel prices, imports, and competition. However, the company's strategic diversification is showing promise, with the welding division emerging as a star performer and the biotechnology division nearing revenue generation. Management emphasized a strong, debt-free balance sheet and a commitment to sustainable growth through new ventures.

    Highlights

    5
    • Welding division became a 'star performer' with average monthly volumes exceeding 100 tons in Q2 FY26 (6:04, 6:08).

    • Welding division secured key BIS and RDSO approvals, considered 'gold standard for quality in the railway sector' (6:26, 6:33).

    • Biotechnology division is actively gaining traction with 'lucrative meetings' and 'positive response' from distillery companies, with revenue expected 'very soon' (7:11, 16:03, 16:15).

    • Company maintains a 'strong' and 'virtually debt free' balance sheet, providing financial flexibility for growth (9:23, 9:29).

    • Strategic diversification into welding and biotechnology is 'derisking' the business model against core sector cyclicity (9:10).

    Concerns

    4
    • Core cored wire business Q2 volumes declined by 14% year-on-year (4:59).

    • The steel sector faces a 'surge of low cost imports' and 'global steel prices... near a 5-year low', putting 'immense pressure on domestic manufacturers' (3:49, 3:58, 4:15).

    • CapEx cycles in the steel sector have 'slowed down', and the 'urge to finish them as soon as possible' is not evident (12:34, 12:49).

    • The core business is affected by 'persistent varied unethical competition' and 'bad practices' (5:36, 17:03).

    Key financials

    Single quarter

    01 metrics
    1. 01Core Business Volume Growth-14.0%-14.0%YoY

    Order Book

    low confidence

    "While SMLT's own order book was not quantified, management noted that order books at their customers (fabrication and construction houses) are filled, indicating robust demand in the end-user industries for their welding products."

    Source:
    Inferred

    Capital allocation

    2
    medium confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Debt

    Debt disclosed

    Guidance & targets

    5
    CategoryTargetPriority
    Sales
    Welding Business Sales Revenue
    ₹25 crore
    High
    Product Portfolio
    Number of SKUs in Welding Business
    10
    High
    Profitability
    Welding Business EBITDA Margin
    high single digit or low double digit margins
    Medium
    Profitability
    Combined EBITDA contribution from all 3 businesses
    10 to 15%
    Medium
    Revenue
    Biotechnology Division Revenue Start
    very soon
    Medium

    Biotechnology Division Revenue Start

    next quarter
    CurrentNot yet started, in advanced discussions
    TargetRevenue generation commenced

    Why it matters

    The commencement of revenue from the biotechnology division is a key indicator of the success of the company's diversification strategy and a new growth driver.

    So the revenue should start very soon and we'll keep our investors informed about it.

    How to verify

    guidance_and_targets[metric='Biotechnology Division Revenue Start']

    Risks & concerns

    3
    RiskSeverity

    Surge of low-cost steel imports and low global steel prices

    Global steel prices are near a 5-year low, leading to a surge of low-cost imports into India, which is squeezing margins for domestic manufacturers and impacting SMLT's product demand.Management acknowledged

    high

    Slowdown in steel sector CapEx and project execution

    While large steel plants have ongoing CapEx, the 'urge to finish them as soon as possible' has slowed, leading to uncertainty over future capital expenditure for the entire sector and subdued demand for SMLT's products.Management acknowledged

    high

    Unethical competition in the core cored wire business

    The core business experienced a 14% YoY volume decline in Q2 FY26 partly due to 'persistent varied unethical competition' and 'bad practices' in the market.Management acknowledged

    medium

    Q&A highlights

    8

    “So the steel sector had seen massive CapEx cycles and honestly, it has slowed down the big steel plants... But the urge to finish them as soon as possible, I can't see them. So that's one red flag. ... Definitely since the steel, steel prices are at, a five year low, the demand for steel and the urge to manufacture as much as they want to is not happening and which is why the demand for our product is also subdued.”

    Management directly linked the slowdown in steel sector CapEx and low global steel prices to subdued demand for SMLT's core products, highlighting a significant headwind.

    asked by Vikas Kumar

    2 min read5 chapters

    Detailed Narrative

    01

    Strategic Diversification and New Growth Engines

    Sarthak Metals Limited is actively executing its strategy to diversify beyond its core business, aiming for resilience and future readiness. The company has established two new pillars: a high-growth welding consumables division and a high-margin biotechnology division. This diversified portfolio is intended to shield the company from the cyclicity of its core business, which is tied to investment-led economic cycles, by linking new ventures to consumption-driven trends, thereby strategically derisking its business model.

    02

    Challenges in the Core Steel Industry and Cored Wire Business

    The Indian steel industry faces a paradox of strong demand fundamentals driven by infrastructure projects and 'Make in India' initiatives, yet it is challenged by a surge of low-cost imports and global steel prices near a 5-year low. This has put immense pressure on domestic manufacturers, squeezing margins and creating uncertainty for future capital expenditure. Consequently, SMLT's traditional cored wire business saw a 14% year-on-year volume decline in Q2 FY26, partly due to intensified and 'unethical competition' in the market.

    03

    Welding Division: A Star Performer with Expansion Plans

    The welding division has emerged as a star performer, sustaining average monthly volumes of over 100 tons in the September quarter. This success is attributed to an aggressive push through its dealer network and robust demand from fabrication and construction industries. The company achieved a key milestone with BIS and RDSO approvals, which are gold standards for quality in the railway sector, opening new avenues for growth. SMLT plans to expand its SKUs from approximately 5 to 10 within the next 12-24 months and targets ₹25 crore in sales revenue from this division within two years, expecting high single-digit to low double-digit EBITDA margins once established.

    04

    Biotechnology Foray: A High-Margin Future Frontier

    SMLT's foray into biotechnology is gaining traction, with advanced discussions underway with leading ethanol distilleries to integrate its technology solutions. The market opportunity is significant, with bio-consumables valued at approximately ₹1.00 per liter of ethanol produced, and a recent tender by OMCS for ₹1050 crore indicating a market size exceeding ₹1,000 crores. Management expects revenue from this division to start 'very soon' and is actively seeking partnerships with established players to share technologies, aiming for healthy double-digit margins.

    05

    Financial Discipline and Sustainability Initiatives

    The company maintains a disciplined financial strategy, boasting a strong and 'virtually debt-free' balance sheet, providing the flexibility to invest in new growth areas without straining resources. SMLT is also committed to sustainability, utilizing recycled aluminum scrap and operating a 400-kilowatt solar power plant as early steps. This commitment to integrating green practices will deepen across all divisions as the company grows, aligning with global shifts towards sustainability and regulations like the EU's carbon border adjustment mechanism.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.